Выбор редакции

Jefferies follows Goldman's lead last week and initiates Onyx Pharmaceuticals ([[ONXX]] +2.7%) with a buy on valuation, but puts a slightly higher price target on the shares at $44.

Jefferies follows Goldman's lead last week and initiates Onyx Pharmaceuticals (ONXX +2.7%) with a buy on valuation, but puts a slightly higher price target on the shares at $44. Post your comment!
НОВОСТИ ПО ТЕМЕ